The incidence and prevalence of cervicitis depends on the study population. The prevalence of cervicitis is estimated to be 18,000 per 100,000 women diagnosed with gonococcal infection.[1] Cervicitis is relatively more prevalent in HIV-positive women than non-HIV positive women.[2] Among this population, the prevalence of cervicitis is estimated to be 7,400 per 100,000 women diagnosed with HIV infection.[3] The overall prevalence of nongonococcal cervicitis is higher than gonococcal cervicitis.[4] Chlamydia cervicitis is four to five times more prevalent than gonococcal cervicitis.[5][4] However, co-infection of gonococcal and chlamydia cervicitis is higher in PID than in cervicitis.[5] Cervicitis commonly follows the pattern of age prevalence of sexually transmitted infections with the highest incidence among women aged 15-24.[6][7][8] There is no racial predilection to developing cervicitis. The prevalence of cervicitis is higher in under-served communities and developing countries.[9][10]
The prevalence of cervicitis is estimated to be 18,000 per 100,000 women diagnosed with gonococcal infection.[1] The prevalence of cervicitis ranges from 7,600 to 24,900 per 100,000 female sex workers. The broad range is due to variation in demographic location.[11][12]
Cervicitis is relatively more prevalent in HIV-positive women than non-HIV positive women.[2] Among this population, the prevalence of cervicitis is estimated to be 7,400 per 100,000 women diagnosed with HIV infection.[3] Screening and treatment of M. genitalium among HIV-infected individuals may be needed to improve cervical health and reduce morbidity.[3] The overall prevalence of nongonococcal cervicitis is higher than gonococcal cervicitis.[4] Chlamydia cervicitis is four to five times more prevalent than gonococcal cervicitis.[5][4] However, co-infection of gonococcal and chlamydia cervicitis is higher in PID than in cervicitis.[5]